Let-7c inhibits A549 cell proliferation through oncogenic TRIB2 related factors

Ping-Yu Wang1, Yun-Xiao Sun, Shuai Zhang

  • 1Key Laboratory of Tumor Molecular Biology in Binzhou Medical University, Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China.

FEBS Letters
|July 16, 2013
PubMed

Insights

MicroRNAs, including let-7c, can suppress lung cancer. This study shows let-7c inhibits lung adenocarcinoma cell proliferation by targeting TRIB2 and affecting downstream signaling pathways.

Area of Science:

  • Molecular biology
  • Oncology
  • Gene regulation

Background:

  • MicroRNAs play crucial roles in cancer, acting as either tumor suppressors or oncogenes.
  • Understanding the specific mechanisms of microRNAs in lung cancer is vital for developing targeted therapies.

Purpose of the Study:

  • To elucidate the mechanism by which let-7c suppresses lung adenocarcinoma cell proliferation.
  • To identify novel targets of let-7c and their downstream effects in lung cancer.

Main Methods:

  • In vitro and in vivo experiments were conducted to assess the effect of let-7c on lung cancer cell proliferation.
  • Target gene identification and validation were performed, including analysis of TRIB2 expression.
  • Downstream signaling pathways, specifically C/EBP-α and phosphorylated p38MAPK, were investigated.

Main Results:

  • let-7c significantly inhibited the proliferation of lung adenocarcinoma cells.
  • TRIB2 was identified as a direct target of let-7c, with its expression being negatively regulated by let-7c.
  • The activity of C/EBP-α and phosphorylated p38MAPK was notably increased in cells treated with let-7c, indicating their role as downstream effectors.

Conclusions:

  • let-7c acts as a tumor suppressor in lung adenocarcinoma by inhibiting cell proliferation.
  • The mechanism involves the negative regulation of TRIB2 and subsequent modulation of downstream factors like C/EBP-α and p38MAPK.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...